Role of endothelin-1 and thromboxane A2 in renal vasoconstriction induced by angiotensin II in diabetes and hypertension
- 1 December 2002
- journal article
- Published by Elsevier in Kidney International
- Vol. 62 (82) , S2-S7
- https://doi.org/10.1046/j.1523-1755.62.s82.2.x
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- The role of the renin-angiotensin system in the development of cardiovascular diseaseThe American Journal of Cardiology, 2002
- Role of endothelin-1 in hypertension and vascular diseaseAmerican Journal of Hypertension, 2001
- Role of angiotensin II in glomerular injurySeminars in Nephrology, 2001
- Hypertension and Diabetes: the Scope of the ProblemBlood Pressure, 2001
- Molecular mechanisms of diabetic renal hypertrophyKidney International, 1999
- Chronic treatment with losartan ameliorates vascular dysfunction induced by aging in spontaneously hypertensive ratsJournal Of Hypertension, 1998
- The Role of Eicosanoids in Angiotensin-Dependent HypertensionHypertension, 1998
- Losartan reduces constrictor responses to endothelin-1 and the thromboxane A2 analogue in aortic rings from spontaneously hypertensive ratsJournal Of Hypertension, 1997
- Effects of Chronic ET A -Receptor Blockade in Angiotensin II-Induced HypertensionHypertension, 1997
- Acute and chronic effects of thromboxane A2 inhibition on the renal hemodynamics in streptozotocin-induced diabetic ratsKidney International, 1994